Format
Sort by
Items per page

Send to

Choose Destination

Selected items

Items: 20

1.

Utility of QuantiFERON®-TB Gold test in diagnosis and management of suspected tubercular uveitis in India.

Sudharshan S, Ganesh SK, Balu G, Mahalakshmi B, Therese LK, Madhavan HN, Biswas J.

Int Ophthalmol. 2012 Jun;32(3):217-23. doi: 10.1007/s10792-012-9554-0. Epub 2012 Apr 15.

PMID:
22527447
2.

QuantiFERON®-TB Gold In-Tube assay vs. tuberculin skin test in Indonesian children living with a tuberculosis case.

Rutherford ME, Nataprawira M, Yulita I, Apriani L, Maharani W, van Crevel R, Hill PC, Alisjahbana B.

Int J Tuberc Lung Dis. 2012 Apr;16(4):496-502. doi: 10.5588/ijtld.11.0491.

PMID:
22325792
3.

Predictors of discordant tuberculin skin test and QuantiFERON®-TB Gold In-Tube results in various high-risk groups.

Weinfurter P, Blumberg HM, Goldbaum G, Royce R, Pang J, Tapia J, Bethel J, Mazurek GH, Toney S, Albalak R; Tuberculosis Epidemiological Studies Consortium.

Int J Tuberc Lung Dis. 2011 Aug;15(8):1056-61. doi: 10.5588/ijtld.10.0650.

PMID:
21740668
4.

QuantiFERON®-TB gold in-tube performance for diagnosing active tuberculosis in children and adults in a high burden setting.

Rose MV, Kimaro G, Nissen TN, Kroidl I, Hoelscher M, Bygbjerg IC, Mfinanga SG, Ravn P.

PLoS One. 2012;7(7):e37851. doi: 10.1371/journal.pone.0037851. Epub 2012 Jul 12.

5.
6.

The tuberculin skin test versus QuantiFERON TB Gold® in predicting tuberculosis disease in an adolescent cohort study in South Africa.

Mahomed H, Hawkridge T, Verver S, Abrahams D, Geiter L, Hatherill M, Ehrlich R, Hanekom WA, Hussey GD.

PLoS One. 2011 Mar 29;6(3):e17984. doi: 10.1371/journal.pone.0017984. Erratum in: PLoS One. 2011;6(6). doi:10.1371/annotation/b371be66-de38-4ed6-b440-d27c9d7e552c.

7.

Observational study of QuantiFERON®-TB gold in-tube assay in tuberculosis contacts in a low incidence area.

Bergot E, Haustraete E, Malbruny B, Magnier R, Salaün MA, Zalcman G.

PLoS One. 2012;7(8):e43520. doi: 10.1371/journal.pone.0043520. Epub 2012 Aug 24.

8.

Clinical experience of QuantiFERON(®) -TB Gold testing in patients with psoriasis treated with tumour necrosis factor blockers in Taiwan.

Chiu HY, Hsueh PR, Tsai TF.

Br J Dermatol. 2011 Mar;164(3):553-9. doi: 10.1111/j.1365-2133.2010.10137.x. Epub 2011 Feb 17.

PMID:
21083541
9.

Indeterminate QuantiFERON®-TB Gold results in a public health clinic setting.

Banach DB, Harris TG.

Int J Tuberc Lung Dis. 2011 Dec;15(12):1623-30. doi: 10.5588/ijtld.11.0017.

PMID:
22118169
10.

[Comparative performance of QuantiFERON(®)-TB Gold IT versus tuberculin skin test among contact investigations for latent tuberculosis infection].

Delgado Naranjo J, Castells Carrillo C, García Calabuig MÁ, Sáez López I; en representación del Grupo de Trabajo para el estudio de los IGRAS en Bizkaia y Araba (GTIBA).

Med Clin (Barc). 2011 Sep 17;137(7):289-96. doi: 10.1016/j.medcli.2010.11.036. Epub 2011 Apr 27. Spanish.

PMID:
21524761
11.

Diagnostic value of interferon- gamma release assays (QuantiFERON-TB Gold® In Tube) in childhood tuberculosis.

Dayal R, Verma V, Sharma B, Kumar G, Kumar N, Gupta R, Katoch VM, Joshi B, Chauhan DS.

Indian J Pediatr. 2012 Feb;79(2):183-7. doi: 10.1007/s12098-011-0469-y. Epub 2011 Jun 25.

PMID:
21706246
12.

Quantitative and qualitative QuantiFERON(®)-TB gold in-tube results among groups with varying risks of exposure to tuberculosis.

Simpson T, Fox J, Crouse K, Field K.

Heart Lung. 2012 Nov-Dec;41(6):553-61. doi: 10.1016/j.hrtlng.2012.06.005. Epub 2012 Jul 27.

PMID:
22840377
13.

Serial testing of Malaysian health care workers with QuantiFERON®-TB Gold In-Tube.

Rafiza S, Rampal KG.

Int J Tuberc Lung Dis. 2012 Feb;16(2):163-8. doi: 10.5588/ijtld.11.0364.

PMID:
22236915
14.

Application of the QuantiFERON®-TB Gold test in erythema induratum.

Sim JH, Whang KU.

J Dermatolog Treat. 2014 Jun;25(3):260-3. doi: 10.3109/09546634.2012.699178. Epub 2012 Sep 19.

PMID:
22920648
15.

Medium-throughput SNP genotyping using mass spectrometry: multiplex SNP genotyping using the iPLEX® Gold assay.

Millis MP.

Methods Mol Biol. 2011;700:61-76. doi: 10.1007/978-1-61737-954-3_5.

PMID:
21204027
16.

Programmatic impact of using QuantiFERON®-TB Gold in routine contact investigation activities.

Grinsdale JA, Ho CS, Banouvong H, Kawamura LM.

Int J Tuberc Lung Dis. 2011 Dec;15(12):1614-20. doi: 10.5588/ijtld.11.0102.

PMID:
22118167
17.

Glutathione-mediated release of Bodipy® from PEG cofunctionalized gold nanoparticles.

Kumar D, Meenan BJ, Dixon D.

Int J Nanomedicine. 2012;7:4007-22. doi: 10.2147/IJN.S33726. Epub 2012 Jul 25.

19.

The MIT D-lab electricity-free PortaTherm™ incubator for remote testing with the QuantiFERON®-TB Gold In-Tube assay.

Dominguez M, Smith A, Luna G, Brady MF, Austin-Breneman J, Lopez S, Yataco R, Moore DA.

Int J Tuberc Lung Dis. 2010 Nov;14(11):1468-74.

20.

Error occurred: cannot get document summary

PMID:
11967415

Supplemental Content

Support Center